0001462573-18-000001.txt : 20180131
0001462573-18-000001.hdr.sgml : 20180131
20180131172604
ACCESSION NUMBER: 0001462573-18-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180131
DATE AS OF CHANGE: 20180131
EFFECTIVENESS DATE: 20180131
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: AgeX Therapeutics, Inc.
CENTRAL INDEX KEY: 0001708599
IRS NUMBER: 821436829
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-304563
FILM NUMBER: 18563832
BUSINESS ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
BUSINESS PHONE: 510-521-3390
MAIL ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
D
1
primary_doc.xml
X0708
D
LIVE
0001708599
AgeX Therapeutics, Inc.
1010 ATLANTIC AVENUE
SUITE 102
ALAMEDA
CA
CALIFORNIA
94501
510-521-3390
DELAWARE
None
None
Corporation
true
2017
Michael
D.
West
1010 Atlantic Avenue
Suite 102
Alameda
CA
CALIFORNIA
94501
Executive Officer
Director
President and CEO
Russell
Skibsted
1010 Atlantic Avenue
Suite 102
Alameda
CA
CALIFORNIA
94501
Executive Officer
Chief Financial Officer
Alfred
D.
Kingsley
150 E. 57th Street
Suite 24E
New York
NY
NEW YORK
10022
Executive Officer
Director
Chairman
Michael
H.
Mulroy
1010 Atlantic Avenue
Suite 102
Alameda
CA
CALIFORNIA
94501
Director
Not Applicable
BioTime, Inc.
1010 Atlantic Avenue
Suite 102
Alameda
CA
CALIFORNIA
94501
Promoter
Parent company of Issuer
Biotechnology
Decline to Disclose
- 06b
false
2018-01-16
false
true
true
false
2500
1000000
462500
537500
false
20
0
0
360000
true
Amount includes payments to parent company for use of office and laboratory facilities and administrative and finance personnel, and salaries of executive officers.
false
AgeX Therapeutics, Inc.
/s/ Russell Skibsted
Russell Skibsted
Chief Financial Officer
2018-01-31